Drug maker Cipla has sent a legal notice to US-based NGO AIDS Healthcare Foundation that had alleged the company was selling its HIV drug 'Viraday' at a higher price in the domestic market.
Cipla Joint Managing Director Aman Lulla confirmed the development but did not give any detail.
"Yes, we have sent a legal notice to AIDS Healthcare Foundation (AHF) and our response to AHF's allegations remains unchanged," Lulla said.
The NGO had earlier brought out advertisements in various newspapers alleging overpricing of 'Viraday' by Cipla.
Taking cognizance over the advertisements, the Monopolies and Restrictive Trade Practices Commission yesterday directed the Director General of Investigation and Registration (DGIR) to probe the issue and submit a report within 60 days.
The NGO had alleged that Cipla is exporting its HIV/AIDS drug Viraday to African countries at Rs 21,200 per patient a year, while the same for Indian patients cost over Rs 54,000.
"It is shocking that AIDS Healthcare Foundation is spending lakhs of rupees on advertisements in various newspapers distorting facts and making baseless allegations," Cipla had said in a statement on August 9.
While questioning the agenda of the NGO, Cipla had said while it has not sold Viraday in Africa, the company sold other anti-AIDS drugs to National AIDS Control Organisation in India at the same prices as in Africa.